Mindray Medical International Ltd (ADR)  

(Public, NYSE:MR)   Watch this stock  
Find more results for MR
+0.01 (0.04%)
Feb 8 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 26.91 - 27.29
52 week 21.80 - 33.83
Open 27.20
Vol / Avg. 2.28M/746,464.00
Mkt cap 3.23B
P/E 18.34
Div/yield 0.40/1.47
EPS 1.49
Shares 88.18M
Beta 1.15
Inst. own 84%
Mar 7, 2016
Q4 2015 Mindray Medical International Ltd Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Feb 25, 2016
Mindray Medical International Ltd Extraordinary Shareholders Meeting - 10:00PM EST - Add to calendar
Dec 27, 2015
Mindray Medical International Ltd Annual Shareholders Meeting
Dec 9, 2015
Mindray Medical International Ltd Annual Shareholders Meeting (Estimated)
Nov 13, 2015
Q3 2015 Mindray Medical International Ltd Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 15.93% 15.04%
Operating margin 17.92% 14.55%
EBITD margin - 19.30%
Return on average assets 8.37% 8.00%
Return on average equity 12.70% 12.40%
Employees 8,400 -
CDP Score - -


Mindray Building Keji 12th Road South, Hi-tech Ind. Park Nanshan
+86-755-26582888 (Phone)
+86-755-26582680 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.

Officers and directors

Xiting Li Executive Chairman, President, Co-Chief Executive Officer
Age: 63
Bio & Compensation  - Reuters
Hang Xu Chairman of the Board
Age: 52
Bio & Compensation  - Reuters
Minghe Cheng Co-Chief Executive Officer, Chief Strategic Officer
Age: 53
Bio & Compensation  - Reuters
Alex Lung Chief Financial Officer
Age: 43
Bio & Compensation  - Reuters
Jianxin Wang Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Fannie Lin Fan Group General Counsel, Secretary of Board of Directors
Age: 42
Bio & Compensation  - Reuters
Ronald H. Ede Director
Age: 56
Bio & Compensation  - Reuters
Qiyao Wu Director
Age: 78
Bio & Compensation  - Reuters
I-Yin Hsu Independent Director
Age: 40
Bio & Compensation  - Reuters
Kern Lim Independent Director
Age: 44
Bio & Compensation  - Reuters